Prostate cancer in black and white Americans.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 12716039)

Published in Cancer Metastasis Rev on March 01, 2003

Authors

Sreekanth Reddy1, Marc Shapiro, Ronald Morton, Otis W Brawley

Author Affiliations

1: Winship Cancer Institute, Emory University, Atlanta, Georgia, USA. kanthi_reddy@hotmail.com

Articles citing this

Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States. Cancer Epidemiol Biomarkers Prev (2012) 1.14

Lower vitamin-D production from solar ultraviolet-B irradiance may explain some differences in cancer survival rates. J Natl Med Assoc (2006) 1.07

The association of perceived discrimination with low back pain. J Behav Med (2008) 1.06

Evaluation of prostate cancer characteristics in four populations worldwide. Can J Urol (2008) 1.06

Molecular mechanisms involving prostate cancer racial disparity. Am J Transl Res (2009) 1.02

Integration of prostate cancer clinical data using an ontology. J Biomed Inform (2009) 0.90

Prostate cancer susceptibility Loci identified on chromosome 12 in African Americans. PLoS One (2011) 0.89

A computer-tailored intervention to promote informed decision making for prostate cancer screening among African American men. Am J Mens Health (2008) 0.89

Androgen receptor-target genes in african american prostate cancer disparities. Prostate Cancer (2013) 0.88

Correlates of trabecular and cortical volumetric BMD in men of African ancestry. J Bone Miner Res (2009) 0.87

Natural history and correlates of hip BMD loss with aging in men of African ancestry: the Tobago Bone Health Study. J Bone Miner Res (2009) 0.83

Emergent trends in the reported incidence of prostate cancer in Nigeria. Clin Epidemiol (2012) 0.81

ROBO1, a tumor suppressor and critical molecular barrier for localized tumor cells to acquire invasive phenotype: study in African-American and Caucasian prostate cancer models. Int J Cancer (2014) 0.81

Addressing the contribution of previously described genetic and epidemiological risk factors associated with increased prostate cancer risk and aggressive disease within men from South Africa. BMC Urol (2013) 0.80

Isolation and genome-wide expression and methylation characterization of CD31+ cells from normal and malignant human prostate tissue. Oncotarget (2013) 0.80

Molecular basis for prostate cancer racial disparities. Front Biosci (Landmark Ed) (2017) 0.78

Rates of and risk factors for trabecular and cortical BMD loss in middle-aged and elderly African-ancestry men. J Bone Miner Res (2015) 0.77

Pathological outcomes and strategies to achieve optimal cancer control during robotic radical prostatectomy in Asian-Indian men. Indian J Urol (2011) 0.77

Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer. Nat Commun (2017) 0.76

Articles by these authors

Effect of dutasteride on the risk of prostate cancer. N Engl J Med (2010) 12.78

Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71

Are racial and ethnic minorities less willing to participate in health research? PLoS Med (2005) 7.88

Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2010) 4.76

Survival of blacks and whites after a cancer diagnosis. JAMA (2002) 4.27

Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2009) 3.25

Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat (2002) 3.19

American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat (2008) 2.97

Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2011) 2.76

Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene. J Clin Oncol (2013) 2.23

Comparison of high-field-strength versus low-field-strength MRI of the shoulder. AJR Am J Roentgenol (2003) 2.21

Profiles in patient safety: emergency care transitions. Acad Emerg Med (2003) 2.18

American society of clinical oncology policy statement: disparities in cancer care. J Clin Oncol (2009) 2.12

Low-dose spiral CT screening and evaluation of the solitary pulmonary nodule. Oncology (Williston Park) (2014) 2.06

Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening. CA Cancer J Clin (2015) 1.97

Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin (2014) 1.95

The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol (2008) 1.93

Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin (2013) 1.75

Palliative care and the quality of life. J Clin Oncol (2011) 1.75

The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE study. J Urol (2010) 1.73

Decreased morning serum cortisol levels in children with asthma treated with inhaled fluticasone propionate. Pediatrics (2002) 1.71

Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst (2002) 1.44

High prevalence of triple-negative tumors in an urban cancer center. Cancer (2008) 1.43

Lung function changes in asthmatic children treated with HFA-BDP. Pediatr Pulmonol (2011) 1.42

Effects of untreated syphilis in the negro male, 1932 to 1972: a closure comes to the Tuskegee study, 2004. Urology (2005) 1.42

Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer (2010) 1.38

Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population. Cancer (2008) 1.36

Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results program. Cancer (2010) 1.28

Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis. Am J Clin Oncol (2008) 1.28

Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States. Cancer Epidemiol Biomarkers Prev (2012) 1.14

Profiles in patient safety: medication errors in the emergency department. Acad Emerg Med (2004) 1.12

Racial disparities in colorectal cancer. Curr Probl Cancer (2007) 1.11

From the guest editors: introduction for the impact of health care reform on cancer patients. Cancer J (2010) 1.08

Colorectal carcinoma in black and white race. Cancer Metastasis Rev (2003) 1.07

Prostate cancer: current evidence weighs against population screening. CA Cancer J Clin (2009) 1.05

High-fidelity medical simulation as an assessment tool for radiology residents' acute contrast reaction management skills. J Am Coll Radiol (2009) 1.00

Myeloma and race: a review of the literature. Cancer Metastasis Rev (2003) 1.00

The globalization of tobacco use: 21 challenges for the 21st century. CA Cancer J Clin (2010) 1.00

Disparities in medical care among commercially insured patients with newly diagnosed breast cancer: opportunities for intervention. Cancer (2010) 0.99

Introducing the 2010 American Cancer Society prostate cancer screening guideline. CA Cancer J Clin (2010) 0.99

Risk-based mammography screening: an effort to maximize the benefits and minimize the harms. Ann Intern Med (2012) 0.98

Is race really a negative prognostic factor for cancer? J Natl Cancer Inst (2009) 0.97

The study of accrual to clinical trials: can we learn from studying who enters our studies? J Clin Oncol (2004) 0.97

Racial disparities in lung cancer. Curr Probl Cancer (2007) 0.96

NIH consensus development statement on hydroxyurea treatment for sickle cell disease. NIH Consens State Sci Statements (2008) 0.95

Examining racial differences in diffuse large B-cell lymphoma presentation and survival. Leuk Lymphoma (2013) 0.95

A black-white comparison of the quality of stage-specific colon cancer treatment. Cancer (2010) 0.93

Characteristics and treatment modalities for African American women diagnosed with stage III breast cancer. Cancer (2009) 0.90

Avoidable cancer deaths globally. CA Cancer J Clin (2011) 0.90

Taking action to ease suffering: advancing cancer pain control as a health care priority. CA Cancer J Clin (2009) 0.89

Some perspective on black-white cancer statistics. CA Cancer J Clin (2002) 0.89

Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages. Am J Cancer Res (2013) 0.89

Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study. Clin Ther (2010) 0.88

Racial differences in the incidence and outcomes for patients with hematological malignancies. Curr Probl Cancer (2007) 0.88

Inhaled corticosteroids in children with asthma: pharmacologic determinants of safety and efficacy and other clinical considerations. Paediatr Drugs (2007) 0.87

MR accuracy and arthroscopic incidence of meniscal radial tears. Skeletal Radiol (2002) 0.86

MR arthrography of postoperative knee: for which patients is it useful? Radiology (2003) 0.86

Informed consent for prostate-specific antigen-based screening. Urology (2003) 0.84

A research agenda for radiation oncology: results of the radiation oncology institute's comprehensive research needs assessment. Int J Radiat Oncol Biol Phys (2012) 0.84

Lung cancer and race: equal treatment yields equal outcome among equal patients, but there is no equal treatment. J Clin Oncol (2005) 0.82

Health care policy and cancer survivorship. Cancer (2013) 0.82

CDC Grand Rounds: the future of cancer screening. MMWR Morb Mortal Wkly Rep (2015) 0.82

The effect of seatbelt use on injury patterns, disposition, and hospital charges for elders. Acad Emerg Med (2002) 0.81

Peak window of suicides occurs within the first month of diagnosis: implications for clinical oncology. Psychooncology (2011) 0.81

Prostate cancer screening; is this a teachable moment? J Natl Cancer Inst (2009) 0.81

The National Breast and Cervical Cancer Early Detection Program: toward a system of cancer screening in the United States. Cancer (2014) 0.80

Loss of asthma control in pediatric patients after discontinuation of long-acting Beta-agonists. Pulm Med (2012) 0.80

Complications of rotator cuff surgery in which bioabsorbable anchors are used. AJR Am J Roentgenol (2003) 0.79

The potential for prostate cancer chemoprevention. Rev Urol (2002) 0.77

Usefulness of simultaneous acquisition of spatial harmonics technique for MRI of the knee. AJR Am J Roentgenol (2004) 0.77

Prevalence of meniscal radial tears of the knee revealed by MRI after surgery. AJR Am J Roentgenol (2004) 0.76

Usefulness of the simultaneous acquisition of spatial harmonics technique during MRI of the shoulder. AJR Am J Roentgenol (2003) 0.75

Phase III prostate cancer chemoprevention trials. Recent Results Cancer Res (2014) 0.75

Oophorectomy in carriers of BRCA mutations. N Engl J Med (2002) 0.75

Information over exaggeration. US News World Rep (2009) 0.75

Curbing tobacco's toll starts with the professionals: World No Tobacco Day. Lancet (2005) 0.75

1509: ED QSOFA SCORE: A SIMPLE PREDICTOR FOR ADVERSE OUTCOMES FOLLOWING ADMISSION FOR BLUNT TRAUMA. Crit Care Med (2016) 0.75

Granulomatous pleuritis caused by histoplasmosis in a healthy child. Pediatr Pulmonol (2011) 0.75

Chemoprevention in prostate cancer. Curr Probl Cancer (2004) 0.75

New ACS chief medical officer. Interview by Carrie Printz. Cancer (2008) 0.75

A brief history of the American Cancer Society Extramural Research Program. CA Cancer J Clin (2012) 0.75

The argument for breast cancer screening. Clin Adv Hematol Oncol (2014) 0.75

Reviewer acknowledgment 2015. CA Cancer J Clin (2015) 0.75